proteolysis leading to a higher net protein deposition. Second, burn victims spend days and/or months in intensive care unit during the acute phase after injury. This results in loss of mobility, loss of lean body mass, and delayed start of rehabilitation. Third, burn patients undergo numerous reconstructive surgeries in years after wound healing has occurred. Major surgeries are known stressors for the catabolic state. The combination of the acute burn injury, prolonged intensive care unit stays, and years of reconstruction surgery render the skeletal muscle persistently catabolic, making amelioration of muscle wasting an important consideration during the treatment of pediatric burn patients.
Studies have shown that the tissue response to nutritional signaling (eg, amino acids) plays a critical role in protein net deposition via coordination of protein synthesis and breakdown mechanisms. In normal conditions, amino acid abundance increases muscle protein synthesis with no change or decrease in the breakdown rate, resulting in an increased net protein deposition. [7] [8] [9] [10] In critical or catabolic conditions, this depends on the severity of the condition. In less severe critical illness, there are milder changes in both protein synthesis and breakdown rates. [11] [12] [13] Whereas in severe cases, namely acute phase after burn injury, amino acid availability increases protein synthesis but this increase is not sufficient to match the increase in breakdown and prevent the protein loss. 14 It is not known, however, how the skeletal muscle of pediatric burn patients responds to amino acid supplementation at later periods after burn injury, for example, 6 month postinjury.
Therefore, in this study we examined the effect of a steady state amino acid (AA) infusion (Travasol) on leg muscle protein turnover in pediatric burn patients at 6 month postinjury compared with that of healthy subjects. We also examined whole-body and whole-body nonmuscle basal and AA affected protein breakdown rates. Nonmuscle protein turnover represents protein turnover from tissues other than muscle, such as liver. We hypothesize that in burn victims, protein turnover is unresponsive to the anabolic signaling of AAs.
METHODS

Patients
A total of 10 pediatric patients [7.4 ± 3.8 years; 27.4 ± 14.7 kg; 120 ± 24.2 cm, mean ± SD] that had acute burn treatment at Shriners Hospital for Children, Galveston, TX, and returned for their 6-month follow-up/reconstructive surgery visit participated in a stable isotope tracer study. This project was a part of a larger clinical trial evaluating the effect of anabolic agents on muscle mass preservation after burn injury. These patients were randomized to a control group and received only standard of care during acute burn treatment period and long term follow up. The study was performed under a University of Texas Medical Branch (UTMB) institutional review board approved protocol. Child assent and parental permission were obtained from each patient and patient's guardian before enrollment into the study. at UTMB, Galveston, TX. Portions of these data were previously presented elsewhere. 10 Before participation in the study, all subjects gave informed written consent according to guidelines established by the institutional review board at UTMB.
All stable isotope studies were performed in the postabsorptive state (fasted overnight, 6-12 hours). After baseline blood samples for background amino acid enrichment were drawn, a primed continuous infusion of L-[ring-2 H 5 ]-phenylalanine (Cambridge Isotope laboratories, Andover, MA) was initiated at a prime dose of 3.2 and 2 μmol·kg −1 and an infusion rate (IR) of 0.08 and 0.05 μmol·kg −1 ·min −1 for burn patients and controls, respectively.
Stable Isotope Study
All subjects were admitted into the hospital the night before the tracer study. Before the tracer study, dual 3F polyethylene catheters (Cook, Inc, Bloomington, IN) were inserted under local anesthesia (1% lidocaine) into the femoral artery and vein of one leg. In addition, pediatric burn patients were sedated with ketamine (4 mg/kg intramuscularly) before the catheter placement procedure. In all burn patients, both legs had healed burn or donor harvest site wounds, so there were no differences between limbs in measurement of protein kinetics. Femoral catheters were used for arteriovenous blood sampling and infusion of indocyanine green for determination of leg blood flow. In addition, indwelling catheters were placed in the antecubital vein of each arm for infusion of isotopes and blood sampling for blood flow measurements.
Blood samples to measure plasma phenylalanine enrichment were collected simultaneously from the femoral artery and vein during the last hour of each period-postabsorptive or AA infusion ( Fig. 1) .
Biopsies of the Vastus lateralis for calculation of muscle protein fractional synthesis rate (FSR) were obtained at 2, 5, and 8 hour of tracer infusion using a 5-mm Bergström needle (Stille, Stockholm, Sweden) ( Fig. 1 ). Tissue was immediately frozen in liquid nitrogen and stored at -80•C until further analysis.
A continuous infusion (IR = 0.05 mg/min) of indocyanine green (Akron, Buffalo Grove, IL) was used for leg blood flow measurements ( Fig. 1 ) as previously described. 10, 15 After the basal period (0-5 h), a primed (prime dose = 0.45 mL/kg) continuous (IR = 1.35 mL·kg −1 ·min −1 ) infusion of 10% Travasol (Clintec Nutrition, Deerfield, IL; total amino acids = 100 mg/mL) was initiated and maintained until 8 h. One hundred milliliter of Travasol solution contains 730-mg leucine, 600-mg isoleucine, 580-mg lysine, 580-mg valine, 560-mg phenylalanine, 480-mg histidine, 420-mg threonine, 400-mg methionine, 180-mg tryptophan, 2.07-g alanine, 1.15-g arginine, 1.03-g glycine, 680-mg proline, 500mg serine, and 40-mg tyrosine.
At the end of the study, peripheral lines and femoral catheters were removed or for the burn patients, were left in place for use at the next reconstructive surgery as required.
ANALYTICAL METHODS
Blood
Blood samples for the measurement of phenylalanine enrichment and concentration were collected as previously described. 10, 15 Briefly, arteriovenous blood samples were collected in preweighed tubes containing 15% sulfosalicylic acid. A known internal standard was added to the blood samples (100 μL/mL of blood) for the measurement of blood phenylalanine concentration. After deproteinization blood amino acids were separated using cation exchange chromatography. 15 The enrichments (tracer-to-tracee ratio) in arterial and venous blood samples were determined on their tertbutyldimethylsilyl derivatives using gas chromatograph-mass spectrometry [GC-MS) HP 5989; Hewlett-Packard, Palo Alto, CA] with electron impact ionization.
Serum indocyanine green concentration was measured by means of a spectrophotometry at λ = 805 nm.
Muscle
Muscle samples were weighed and protein precipitated with 800 μL of 10% perchloric acid. The supernatant was collected after homogenization of the tissue and centrifugation. The amino acids in the supernatant were then separated using cation exchange chromatography. 15 The isotopic enrichment of the intracellular phenylalanine was determined on their tert-butyldimethylsilyl derivatives by GC-MS in electron impact mode. The remaining pellet was washed as previously described, 10, 15 dried at 50 • C overnight, and hydrolyzed in 6 N HCl at 110 • C for 24 hour. The hydrolysate was then passed over a cation exchange column and phenylalanine enrichment was measured by GC-MS in the same manner as the intracellular portion. 15 
CALCULATIONS
Leg Muscle Protein Kinetics
As phenylalanine is neither synthesized nor oxidized in the periphery, the rates of appearance (R a ) and disappearance (R d ) of this amino acid in the femoral arterial and venous plasma pools reflect leg skeletal muscle protein breakdown and synthesis, respectively. The assumptions and limitations of the kinetic model have been described elsewhere. 10, 15 Because calculation of the model kinetics depends on the maintenance of steady-state physiological conditions, we primed the amino acids and infused at a constant infusion rate. Finally, arteriovenous sampling took place in the last hour of the 3-hour amino acid infusion once blood amino acid concentrations and enrichments achieved steady state. The phenylalanine kinetic rates within the leg were calculated and standardized for leg volume.
Whole-Body Protein Kinetics
Whole-body amino acid R a represented by phenylalanine plasma kinetics was calculated according to the standard equation, that is, tracer infusion rate divided by arterial enrichment. Because subjects were fasted, no correction for protein intake was needed. For the amino acid infusion period whole-body R a was corrected for the amount of the infused phenylalanine. Whole-body muscle amino acid R a was calculated from leg muscle amino acid R a , corrected for the whole-body muscle mass using an assumed value of 4.5. 15 Whole-body nonmuscle amino acid R a was calculated by subtracting whole-body muscle R a from total whole-body R a .
Muscle Protein Fractional Synthesis Rate
Calculations of the muscle protein FSR were based on the precursor-product method, using intracellular free and bound protein tracer enrichments in the muscle biopsy as precursor and product, respectively.
The specific equations for the calculations described above are:
Leg muscle protein rate of appearance: IR a = R d -NB 4. Transport into the leg: 
where NB is net protein deposition in the leg muscle; lR d and lR a are the rates of disappearance and appearance of phenylalanine within the leg, respectively; C A and C V are the blood free phenylalanine concentrations of the femoral artery and vein; E A and E V are the blood free phenylalanine enrichments (tracer/trace ratio) in the femoral artery and vein; and BF is leg blood flow in mL/min/ 100 mL leg; wbR a is whole-body rate of appearance of phenylalanine; IR-tracer phenylalanine infusion rate; wbmR a , whole-body muscle rate of appearance of phenylalanine; wbeR a , whole-body endogenous rate of appearance of phenylalanine; FSR is fractional synthesis rate of muscle protein; E f and E M are the enrichments of free and bound amino acid respectively, and t is the time interval in minutes between 2 sequential biopsies. Leg and whole-body protein R d , R a , and NB are expressed in nmol Phe/min/100 mL leg volume and μmol Phe/min/kg, respectively. Fractional synthesis rate was expressed in units of percent per hour (%/hour).
Data Presentation and Statistical Analysis
Data are presented as Means ± SE, unless otherwise stated. A 2-way repeated-measures analysis of variance with the factors time and treatment with post hoc Tukey correction was used to assess differences in measurements. A P value less than 0.05 was considered statistically different.
RESULTS
General demographics and phenylalanine kinetic parameters are presented in Table 1 .
Phenylalanine enrichments and concentrations in the femoral artery (FA) and vein (FV) were in steady-state conditions over the last 1 hour of each study period in both groups. After start of AA infusion, phenylalanine enrichments in the FA and FV significantly decreased (P < 0.05), (FA: Burn: 0.078 ± 0.027 vs 0.044 ± 0.012; Control: 0.064 ± 0.005 vs 0.039 ± 0.004; FV: Burn: 0.074 ± 0.029 vs 0.042 ± 0.011; Control: 0.049 ± 0.003 vs 0.035 ± 0.003, Basal vs AA, respectively) whereas phenylalanine concentration significantly increased (P < 0.05), (FA: Burn: 66 ± 12 vs 113 ± 31; Control: 62 ± 3 vs 113 ± 12, FV: Burn: 67 ± 11 vs 133 ± 30; Control: 70 ± 3 vs 103 ± 9, Basal vs AA, respectively). During AA infusion, FV phenylalanine concentration was significantly (P < 0.05) higher in the burn patients than in the control groups. The rates of tracer infusion were greater in the patients than in the controls (see Methods); thus the values of AA enrichments cannot be directly compared. Nonetheless, the ratio between AA enrichments in muscle and the artery were not significantly different between the groups and periods (Burn: 0.63 ± 0.08 vs 0.81 ± 0.05; Control: 0.63 ± 0.04 vs 0.77 ± 0.05, Basal vs AA, respectively, P > 0.05). In the control group, muscle intracellular enrichment significantly decreased at the end of the AA period compared with the basal period (Basal vs AA, 0.039 ± 0.004 vs 0.03 ± 0.004, P < 0.05), in the burn group although the enrichment decreased, the difference did not reach statistical significance (Basal vs AA, 0.041 ± 0.007 vs 0.034 ± 0.003, P = 0.085).
Phenylalanine kinetic data are presented in Table 1 . The rate of leg blood flow was higher in burn patients but the difference did not reach statistical significance because of the variability in the burn group (Burn: 9 ± 5 vs 12 ± 13 mL/min per 100 mL leg volume; Control: 4 ± 2 vs 5 ± 2, Basal vs AA, respectively). Consequently, the rate of phenylalanine delivery to the leg was significantly higher (P < 0.05) in the burn group in both periods (Table 1 ). It was also significantly increased (P < 0.05) in the burn group by AA infusion. Inward transport was also significantly increased in both groups during AA infusion; however, there was no difference between the groups during AA infusion. Outward transport was not different between the groups and periods. During AA infusion phenylalanine shunting significantly increased (P < 0.05) in the burn patients but not in the control subjects. And, this increase in shunting in burn patients was significantly higher (P < 0.05) than the increase in the control group with AA infusion.
Leg muscle protein kinetic data are presented in Figure 2 . There was no significant difference in postabsorptive net protein deposition in burn patients compared to healthy young controls. Amino acids infusion significantly increased (P < 0.05) muscle protein synthesis, represented by (R d ) in both groups ( Fig. 2A) compared to the basal period. Amino acids infusion did not affect significantly leg muscle protein breakdown, represented by rate of appearance (R a ) in either group (Fig. 2B) ; however, in the control group it decreased by 21% (P > 0.05) whereas in the burn group it increased by 36% (P > 0.05). As a result, during AA infusion muscle protein net deposition did not change in the burn group but significantly increased in the control group (P < 0.05) (Fig. 2C) .
Muscle protein FSR increased in both groups during AA infusion (Basal vs AA, 0.115 ± 0.037 vs 0.161 ± 0.045 and 0.057 ± 0.004 vs 0.11 ± 0.012%/h, Burn and Control, respectively), however, it did not reach statistical significance (P = 0.089 and P = 0.074; Burn and Control, respectively).
Whole-body protein turnover data are presented in Figure 3 . Basal whole-body protein R a was significantly higher (P < 0.05) in burn patients than in the control group (Fig. 3A) . During AA infusion in burn patients whole-body protein R a did not change unlike in controls (Fig. 3A) , where it was significantly suppressed (P < 0.05) compared to the basal level within the group and the AA period of the burn group. There was no difference in whole-body muscle R a between the groups (Fig. 3B ) during both study periods. Basal whole-body nonmuscle protein R a was 189% higher in the burn group than in the control group (Fig. 3C) but the difference did not reach statistical significance (P = 0.13). Similarly, AA stimulated wholebody nonmuscle protein R a was 300% higher in the burn group but again the difference did not reach statistical significance (P = 0.07) (Fig. 3C ).
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DISCUSSION
The first principal finding of this study is that in the pediatric burn patient population at 6 months postburn injury leg muscle protein net deposition is unresponsive to AA infusion (Fig. 2) . When AAs were infused, leg muscle protein synthesis (R d ) significantly increased (P < 0.05) in both groups. However, in the burn group there was a simultaneous (although nonsignificant) increase in protein breakdown (R a ), resulting in no change in protein net deposition (NB). This is unlike healthy young adults, in whom the breakdown rate decreased (although nonsignificantly), resulting in a significant increase (P < 0.05) in protein NB (Fig. 2) .
Delivery of phenylalanine to the leg was significantly increased by burn injury (Table 1) . Phenylalanine kinetic data demonstrate that the AAs transport system is not affected, but arterio-venous shunting is increased in burns. One speculation to explain this phenomenon is that due to an increase in protein breakdown muscle intracellular phenylalanine concentration was elevated therefore the inward transport was working against a greater concentration gradient between blood and intracellular space, so did not increase even though there was greater phenylalanine delivery to the leg. Perhaps the protein synthesis rate is at a maximal level, but is not sufficient to counteract the massive increase in protein breakdown.
Critical conditions or stress (eg, exercise training) increase both protein synthesis and breakdown rates; but the degree of change depends on the degree of the severity of one's condition. For example, exogenous AAs enhance muscle anabolism after exercise by increasing muscle protein synthesis and suppressing the exercise-induced breakdown. 7, 16 In patients with less severe critical illness than burn injury changes in protein breakdown are milder along with suppressed rates of synthesis. [11] [12] [13] Our current data demonstrate that AA availability can stimulate muscle protein synthesis in burns. However, the synthesis in response to extra AA availability may be at the maximal level but not sufficient to match the breakdown and consequently prevent the severe protein loss in burns. Given that our patients are pediatric patients who are supposed to be more anabolic than the healthy control adults, we cannot exclude the possibility that synthesis might have been higher if the children were uninjured.
The second principal finding of this study is that whole-body protein breakdown is significantly higher in burn patients and also unresponsive to AA infusion ( Fig. 3 ). Whole-body protein breakdown includes breakdown from muscle tissue and all other organs including liver, gut, and skin. These data are again different from data in healthy adult subjects, where a significant decrease is observed (P < 0.05), but consistent with other observations from catabolic conditions. [17] [18] [19] [20] Also, splanchnic tissue protein breakdown is the main contributor in exercise-and insulin-induced increase in whole-body protein R a . [18] [19] [20] These data demonstrate that splanchnic protein metabolism is readily and significantly stimulated and can be affected by different kinds of stress including burn injury. In the current study we did not measure whole-body and whole-body nonmuscle protein synthesis. Our postulation is that most probably splanchnic protein synthesis also increased during AA infusion. However, evidences suggest that during interventions AAs released from gut are redirected into muscle protein synthesis. 18 Skin is the largest nonmuscle organ and the main organ that is affected in burn injury. Therefore, it is reasonable to question if skin protein breakdown is the main contributor to the increased whole-body protein breakdown. The current studies were conducted 6 months after the injury when the skin wounds are completely healed and mostly hypertrophic scars are developing, therefore, we presume that skin protein synthesis is increased but the breakdown is suppressed. Therefore, we do not think that skin wound protein breakdown is the main contributor in this case; however, future studies to evaluate this possibility would be of interest.
Basal and AA-stimulated whole-body nonmuscle protein breakdown was 189 and 300% higher in the burn group than in the control group, however, the difference did not reach statistical significance (P = 0.13 for the basal; and P = 0.07 for the AA period between the groups). Sample size analysis demonstrated that 25 patients per group would have been required to reach statistical significance with power of 0.8 and α = 0.05. Nevertheless, we conclude that burn pediatric patients are catabolic with elevated protein degradation at whole body level.
A comparison of data from burn pediatric patients to the results from young adults is potentially problematic because differences may be due to age differences rather than burn injury. However, because children are growing, their protein kinetics would be expected to be more anabolic, rather than catabolic. Therefore, the results here may underestimate the true extent of catabolism caused by burns. Unfortunately, it was not possible to obtain data from an age-matched pediatric population; however, several whole-body protein turnover studies have concluded that children and young adults have comparable protein kinetics. [21] [22] [23] [24] Although this is the first study to examine the effects of amino acid infusion in burn patients after recovery, the effects of amino acids in burn patients in the intensive care unit as well as other clinical populations have been studied. van Waardenburg et al, 25 using 15 Nglycine measured whole-body protein turnover in healthy (fasting or fed) children and children with meningococcal septic shock (fed). Healthy children demonstrated significantly suppressed whole-body protein breakdown during feeding; children with meningococcal septic shock demonstrated twice as high protein breakdown rate (P < 0.05) compared with healthy fed children and almost 7-fold increase compared with the fasting children (P < 0.05). Children with meningococcal septic shock also demonstrated significantly increased whole-body protein synthesis rate. Similar results have been reported from patients with cystic fibrosis and patients undergoing elective surgeries. 24, 26 The main conclusions were that breakdown is largely an obligatory response to the severity of the trauma, whereas synthesis responds to substrate availability. Yu et al, 27 showed that feeding significantly increased whole-body protein synthesis and breakdown rates in burn patients, and those values were almost 2-fold higher than the values reported from healthy controls. These results are consistent with our current findings.
The increase in FSR was consistent with the increase in leg muscle protein R d , however, by 2-way repeated-measures analysis of variance analysis the results did not reach statistical significance. In our previous report on the control subjects, 10 muscle protein FSR was significantly increased (P < 0.05, t test) with AA infusion. The explanation on the current nonsignificant result might be because of the results from the burn group. One of the patients demonstrated decreased FSR at AA period compared to the postabsorptive state. If we exclude FSR data from this particular patient from the analysis, P values become 0.003 and 0.015 for burn and control groups, respectively, demonstrating that AA significantly increases muscle protein FSR in both groups. Unfortunately, we do not have an explanation why the FSR data from that patient is inconsistent with others.
In conclusion, at 6-month postinjury in a pediatric patient population tissue protein turnover is unresponsive to AA anabolic signaling and the patients are in more catabolic state rather than anabolic. This can be supported by previous reports that burn injury results in long-lasting increase in catabolic hormones and insulin resistance. [28] [29] [30] Thus, it maybe that nutrition alone is not sufficient for burn children to resume normal growth, and additional interventions (anabolic hormones, exercise) should be indicated. Future studies on the effect of anabolic stimulus to restore tissue protein response to nutrient's anabolic signaling in burns would be of interest.
